Central glutamate signaling in postoperative pain regulation - Renewal

术后疼痛调节中的中枢谷氨酸信号 - 更新

基本信息

  • 批准号:
    10664865
  • 负责人:
  • 金额:
    $ 46.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

Postoperative pain is a major morbidity, and persistent opioid use after surgery has contributed to an epidemic. An improved mechanistic understanding of how pain is regulated within the brain can lead to novel non-opioid analgesic development. The long-term goal of this proposal is to understand the central regulation of postoperative pain. The objective of the current application is to define the role of prelimbic cortex (PL) and anterior cingulate cortex (ACC), two key components of the prefrontal cortex in rodents, in the regulation of acute and chronic postoperative pain. The PL is homologous to human dorsolateral prefrontal cortex that is known to undergo synaptic changes with chronic pain, and the ACC is a well-described region for processing affective component of pain across species. Our central hypothesis is that an imbalance in neural activities in the PL and ACC contributes to symptoms of postoperative pain and thus forms a therapeutic target. Our hypothesis is supported by the current literature showing that the PL has a pain-inhibitory role, whereas the ACC enhances pain aversion, and that chronic pain causes increased excitability in the ACC and hypo-excitability in the PL. It is also supported by our recent results demonstrating that AMPAkines and ketamine, drugs that alter glutamate signaling and shape cortical circuits, reduce pain. In Aim 1, we will test the hypothesis that an imbalance in ACC and PL activities contributes to postoperative pain in awake freely behaving rats. We will use paw incision (PI) to mimic acute reversible incisional pain, and spared nerve injury (SNI) to model chronic pain after intraoperative nerve damage. We will first correlate imbalanced prefrontal activities with pain, by showing a concurrent loss of nociceptive response in the PL and gain of response in the ACC as pain behavior persists, and the resolution of such neural changes as pain resolves, using simultaneous in vivo extracellular recordings of the PL and ACC. Further, to test the causal effect of this imbalance on pain, we will show that optogenetic PL activation, or ACC inhibition, reverses postoperative pain behaviors. Next, we will use optrode recordings to dissect a local pain- regulatory circuit fromthe PL to the ACC. Further, we will use an unbiased supervised machine learning analysis to validate the relationship between the imbalance in PL and ACC activities and the chronicity of postoperative pain. In Aim 2, We will test the hypothesis that pharmacologic and electrical neuromodulation can target imbalanced PL/ACC activities in the postoperative pain state. We will show that AMPAkines and ketamine increase PL outputs and reduce ACC activities to inhibit pain and optimize the timing and dosing regimens for these drugs and test therapeutic synergy. We will also optimize invasive and non-invasive electrical stimulation protocols in the PL to treat pain. This project is innovative because it applies a new systems neuroscience approach with cutting-edge techniques to uncover a central pain-regulatory mechanism. The work is significant because it produces novel applications of FDA-approved drugs (ketamine and APMAkines) for postoperative pain and a blueprint for new deep brain or transcranial stimulation methods to treat pain.
术后疼痛是一种主要的发病率,术后持续使用阿片类药物导致了一种流行病。 对疼痛在大脑中如何调节的机械理解的改进可以导致新的非阿片类药物 止痛药的发展。这项提案的长期目标是理解中央对 术后疼痛。目前应用的目的是定义前脑皮质(PL)和 前扣带回皮质(ACC)是啮齿类动物前额叶皮质的两个重要组成部分,在调节急性脑损伤中起重要作用。 和慢性术后疼痛。PL与人类背外侧前额叶皮质同源,已知 伴随着慢性疼痛经历突触变化,而ACC是一个很好地描述的处理情感的区域 跨物种痛苦的组成部分。我们的中心假设是前额叶和前额叶的神经活动失衡 ACC会导致术后疼痛症状,从而形成治疗靶点。我们的假设是 目前的文献表明,PL具有止痛作用,而ACC则增强 疼痛厌恶,慢性疼痛导致ACC的兴奋性增加,PL的兴奋性降低。它 我们最近的研究结果也支持这一点,即安帕金斯和氯胺酮,这两种改变谷氨酸的药物 发出信号并塑造皮质回路,减轻疼痛。在目标1中,我们将测试Acc不平衡的假设 PL活性参与清醒自由行为大鼠术后疼痛的发生。我们将使用爪状切开术(PI) 模拟急性可逆性切口痛,避免神经损伤(SNI)造模术中慢性疼痛 神经损伤。我们首先将不平衡的前额叶活动与疼痛联系起来,通过显示同时失去 当疼痛行为持续存在时,PL中的伤害性反应和ACC中的反应获得,以及 使用体内同时记录的PL和ACC的细胞外记录,可以缓解疼痛等神经变化。 此外,为了测试这种失衡对疼痛的因果效应,我们将展示光遗传PL激活,或ACC 抑制,逆转术后疼痛行为。接下来,我们将使用光学电极记录来解剖局部疼痛- 从PL到ACC的调节电路。此外,我们将使用无偏监督的机器学习分析 验证PL和ACC活性失衡与术后慢性化的关系 疼痛。在目标2中,我们将测试药物和电神经调节可以靶向的假设 术后疼痛状态下PL/ACC活性失衡。我们将展示安帕金斯和氯胺酮 增加PL产量和降低ACC活性以抑制疼痛并优化时间和剂量方案 并测试这些药物的治疗协同作用.我们还将优化有创和无创电刺激 PL中治疗疼痛的方案。这个项目具有创新性,因为它应用了一种新的系统神经科学。 使用尖端技术来揭示中枢疼痛调节机制。这项工作意义重大 因为它产生了FDA批准的术后药物(氯胺酮和APMAkines)的新应用 以及治疗疼痛的新的脑深部刺激或经颅刺激方法的蓝图。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Deciphering neuronal population codes for acute thermal pain.
  • DOI:
    10.1088/1741-2552/aa644d
  • 发表时间:
    2017-06
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Chen Z;Zhang Q;Tong APS;Manders TR;Wang J
  • 通讯作者:
    Wang J
Local field potential decoding of the onset and intensity of acute pain in rats.
  • DOI:
    10.1038/s41598-018-26527-w
  • 发表时间:
    2018-05-29
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Zhang Q;Xiao Z;Huang C;Hu S;Kulkarni P;Martinez E;Tong AP;Garg A;Zhou H;Chen Z;Wang J
  • 通讯作者:
    Wang J
Ketamine normalizes high-gamma power in the anterior cingulate cortex in a rat chronic pain model.
  • DOI:
    10.1186/s13041-020-00670-w
  • 发表时间:
    2020-09-23
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Friesner ID;Martinez E;Zhou H;Gould JD;Li A;Chen ZS;Zhang Q;Wang J
  • 通讯作者:
    Wang J
Inhibition of the Prefrontal Projection to the Nucleus Accumbens Enhances Pain Sensitivity and Affect.
抑制前额叶向伏核的投射可增强疼痛敏感性和影响力
  • DOI:
    10.3389/fncel.2018.00240
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Zhou H;Martinez E;Lin HH;Yang R;Dale JA;Liu K;Huang D;Wang J
  • 通讯作者:
    Wang J
Intracranial Pharmacotherapy and Pain Assays in Rodents.
啮齿类动物的颅内药物治疗和疼痛测定。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jing Wang其他文献

Electrochemical performance of high-capacity nanostructured Li[Li0.2Mn0.54Ni0.13Co0.13]O2 cathode material for lithium ion battery by hydrothermal method
水热法制备锂离子电池高容量纳米结构Li[Li0.2Mn0.54Ni0.13Co0.13]O2正极材料的电化学性能
  • DOI:
    10.1016/j.electacta.2013.05.118
  • 发表时间:
    2013-09
  • 期刊:
  • 影响因子:
    6.6
  • 作者:
    Xin Wei;Shichao Zhang;Zhijia Du;Puheng Yang;Jing Wang;Yanbiao Ren
  • 通讯作者:
    Yanbiao Ren

Jing Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jing Wang', 18)}}的其他基金

Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP
靶向 Sigma 1 受体作为限制 ROP 神经血管损伤的新疗法
  • 批准号:
    10718424
  • 财政年份:
    2023
  • 资助金额:
    $ 46.99万
  • 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
  • 批准号:
    10267675
  • 财政年份:
    2020
  • 资助金额:
    $ 46.99万
  • 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
  • 批准号:
    10636865
  • 财政年份:
    2020
  • 资助金额:
    $ 46.99万
  • 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
  • 批准号:
    10413216
  • 财政年份:
    2020
  • 资助金额:
    $ 46.99万
  • 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
  • 批准号:
    10030344
  • 财政年份:
    2020
  • 资助金额:
    $ 46.99万
  • 项目类别:
Targeting TGFbeta/PDK4 to Overcome Drug Resistance in Colorectal Cancer
靶向 TGFbeta/PDK4 克服结直肠癌耐药性
  • 批准号:
    10000912
  • 财政年份:
    2018
  • 资助金额:
    $ 46.99万
  • 项目类别:
The Functional Role of LGR5 in Colon Cancer
LGR5 在结肠癌中的功能作用
  • 批准号:
    9311599
  • 财政年份:
    2017
  • 资助金额:
    $ 46.99万
  • 项目类别:
The Functional Role of LGR5 in Colon Cancer
LGR5 在结肠癌中的功能作用
  • 批准号:
    9764643
  • 财政年份:
    2017
  • 资助金额:
    $ 46.99万
  • 项目类别:
The Functional Role of LGR5 in Colon Cancer
LGR5 在结肠癌中的功能作用
  • 批准号:
    9695180
  • 财政年份:
    2017
  • 资助金额:
    $ 46.99万
  • 项目类别:
Data Science Core
数据科学核心
  • 批准号:
    10517259
  • 财政年份:
    2017
  • 资助金额:
    $ 46.99万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 46.99万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了